Merck Bovilis® Vista® 5 VL5 SQ CFP

Shown effective for the vaccination of healthy cattle 6 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 & 2, bovine respiratory syncytial virus (BRSV) and parainfluenza3 virus (PI3), reproductive disease caused by Campylobacter fetus and leptospirosis (caused by Leptospira canicola, L. grippotyphosa, L. hardjo – including the L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona). Effective against urinary shedding of hardjo bovis organisms. Respiratory and reproductive efficacy and duration of immunity has been demonstrated against disease caused by the BVD Type 1b strain.

Indications

This product is for the vaccination of healthy cows and heifers prior to breeding as an aid in the reduction of abortion due to infectious bovine rhinotracheitis (IBR); as an aid in the prevention of fetal infection, including persistently infected calves caused by bovine virus diarrhea virus (BVD) (Types 1 & 2). Reproductive Duration of Immunity (DOI) has been demonstrated to be at least 217 days for IBR and at least 206 days for BVD (Types 1 & 2). In addition, it can be used as an aid in the prevention of disease caused by IBR, BVD (Type 2); and bovine respiratory syncytial virus (BRSV), as an aid in the control of disease caused by BVD (Type 1), and parainfluenza₃ virus (PI₃), as an aid in reducing infertility (reproductive disease caused by Campylobacter fetus), and as an aid in preventing leptospirosis (caused by Leptospira canicola, L. grippotyphosa, L. hardjo – including the L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona) and as an aid in prevention of urinary shedding of hardjo organisms. Respiratory Duration of Immunity (DOI) has been demonstrated to be at least 182 days for IBR, at least 206 days for BVD (Type 1), and at least 200 days for BVD (Type 2). Safe for use in pregnant heifers and cows or calves nursing pregnant cows provided the cows and heifers in the herd are vaccinated prior to breeding, within the previous 12 months, with any of the modified-live IBR and BVD containing vaccine(s) in this product line.

Dosage

2 mL administered subcutaneously 14 to 60 days prior to breeding to healthy cattle 6 months of age or older. Annual revaccination is recommended.

Contact

For additional information, please see the product label.